Sortilin receptor-mediated novel cancer therapy: A targeted approach to inhibit vasculogenic mimicry in ovarian and breast cancers.
Sept. 30, 2020
30 Sept. 2020
Demeule M, Currie J-C, Larocque A, et al.
Location
Poster #4335 presented at: Annual Meeting of the American Association for Cancer Research; June 22-24, 2020; virtual.